VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2 | +100.0% | 20,111 | +5.2% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 19,111 | -34.4% | 0.00% | – |
| Q3 2022 | $4,000 | -77.8% | 29,111 | +35.7% | 0.00% | – |
| Q2 2022 | $18,000 | -28.0% | 21,445 | +3.6% | 0.00% | – |
| Q1 2022 | $25,000 | -37.5% | 20,695 | 0.0% | 0.00% | – |
| Q4 2021 | $40,000 | -37.5% | 20,695 | -12.1% | 0.00% | – |
| Q3 2021 | $64,000 | -13.5% | 23,535 | 0.0% | 0.00% | – |
| Q2 2021 | $74,000 | +94.7% | 23,535 | +29.3% | 0.00% | – |
| Q1 2021 | $38,000 | +322.2% | 18,195 | +37.9% | 0.00% | – |
| Q3 2020 | $9,000 | +50.0% | 13,195 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 13,195 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -44.4% | 13,195 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -35.7% | 13,195 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | – | 13,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |